NeoadDurvalumab+ChemothVSChemotheAlonw/MammaPrintHormRece+HumaEpidGrowFacRecepNegStagII-IIIBreastCa
Ritesh Parajuli
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 14 of 14 Results
EMBER-4: PhIII Imlunestrant vs EndoThera Pts Recieved 2to5 years Adj Endocrine Ther ER+HER2 Recurren
Ritesh Parajuli
- OPEN TO ACCRUAL
PhIII Inavolisib+FulvestrantVSAlpelisib+Fulvestrant Pa w/HormoneRecep+ HER2- PIK3CA BreastCa
Ritesh Parajuli
- OPEN TO ACCRUAL
PhIII Randomized Trial Radiotherapy Optimization for Low-Risk HER2-Positive Breast Cancer" (HERO*)
Erin Heather Healy
- OPEN TO ACCRUAL
Datopotamab Deruxtecan w/orw/out DurvalumabVSInvestigatorsTherapy w/StageI-III Following Neoadj Th
Ritesh Parajuli
- OPEN TO ACCRUAL
Phase I TNBC Targeting DNA Methyltransferases in Metastatic Triple-Negative Breast Cancer
Ritesh Parajuli
- OPEN TO ACCRUAL
PhIII StudyEvaluating Giredestrant+Everolimust Compare w/Exemestane+Everolimus Pts ER+HER2-Breast Ca
Ritesh Parajuli
- OPEN TO ACCRUAL
Ph3StudyGedatolisib Combw/Palbociclib&Fulvestrant toTherapiesw/HR+ HER2+AdvBeastCa PrevTreatw/CDK4/6
Ritesh Parajuli
- OPEN TO ACCRUAL
Ph III Study of Sacituzumab Govitecan + Pembro v. Dr. Choice + Pembro in Pts w/ Trip-Neg Breast Ca
Ritesh Parajuli
- OPEN TO ACCRUAL
Ph II Trial of Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
Rita Mehta
- OPEN TO ACCRUAL
PhIIIDeEscalate of BreastRad for Tx of StgI, Horm Sensitive HER2- Onco Recur Score >/= to 18BreastCa
Rita Mehta
- OPEN TO ACCRUAL
COMPASSHER2 RD Ph III Trial of T-DM1 & Placebo Compared w/ T-DM1 & Tucatinib
Ritesh Parajuli
- OPEN TO ACCRUAL
Blood Collection Protocol for the Analysis of Exosomes in Patients with Breast Cancer
Ritesh Parajuli
- OPEN TO ACCRUAL
Ph II Radium-223 Dichloride in Combination w/ Paclitaxel in Patients w/ Bone Metastatic Breast Ca
Ritesh Parajuli
- OPEN TO ACCRUAL